Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| WESTELL TECH | WSTL | 6.67% |
| STEIN MART I | SMRT | 5.38% |
| ALLIANCE FIB | AFOP | 5.21% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOTT VAC | VAC | 3.27% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Agrium Inc.’s ( AGU - Analyst Report ) second-quarter 2012 adjusted (excluding one-time items other than stock-based compensation expenses) earnings of $5.43 per share exceeded the Zacks Consensus Estimate of $5.36. On a reported basis, earnings came in at $5.44 per share, up 19.8% from $4.54 reported in the year-ago quarter.
Revenues amounted to $6,834 million in the quarter, up 10.3% year over year, and also above the Zacks Consensus Estimate of $6,549 million. Revenues were driven by higher agricultural sales.
Segmental Performance
Retail: The segment posted sales of $5.2 billion in the quarter, reflecting a year-over-year jump of 12%. Strong demand across all crop input products and services led to the increase in sales. Gross profit jumped 10.8% year over year to $1.1 billion. The segment’s earnings from continuing operations before finance costs, income taxes, depreciation and amortization (EBITDA) were a record $605 million, up 14.4% year over year.
Wholesale: The wholesale segment posted net sales of $1.7 billion in the quarter, marginally above the year-ago quarter. Gross profit was the highest in company’s history at $673 million, an increase of 9% from the year-ago quarter. EBITDA increased 11.2% to $686 million. The growth was driven by higher realized selling prices and lower input costs of the nitrogen business.
Advanced Technologies: Advanced Technologies’ gross profit was $36 million, down 2.7% from $37 million in the prior-year quarter. Unplanned outages at the Carseland nitrogen facility resulted in lower sales volumes of the Environmentally Smart Nitrogen (ESN). These also offset the strong earnings posted by the Micronutrients and Evergro acquisitions and increased sales in the Direct Solutions segment in the U.S. EBITDA jumped 11.1% year over year to $20 million.
Acquisition
Agrium, in March 2012, entered into an agreement with Viterra Inc. to acquire the majority of its Agri-products business. The purchase price is expected to be roughly C$1.65 billion. Agrium will acquire the assets from Glencore International plc upon completion of the latter’s acquisition of Viterra.
On August 2, 2012, Agrium and Glencore announced that CF Industries Holdings Inc. ( CF - Analyst Report ) , which owns a 66% interest in the Medicine Hat nitrogen facility, will buy Viterra's 34% interest in the facility for C$915-million. As such, Agrium will not acquire an interest in the Medicine Hat facility. However, the company will continue to benefit from Viterra's operating cash flow on the facility till the closure of the transaction.
Financial Position
Cash provided by operating activities was $1,120 million in the second quarter compared with $76 million at the end of the year-ago quarter. Capital expenditure stood at $514 million versus $246 million in the prior-year quarter. Cash and cash equivalent as of June 30, 2012, was $1,946 million compared with $1,346 million as of December 31, 2011.
Outlook
The company expects crop yields to be lower in 2012 owing to the severe droughts in the country, resulting in high grain prices. High crop prices and tight grain inventories are expected to create huge demand for nutrients in the years ahead.
We currently have a long-term Outperform recommendation on Agrium. The company, which competes with CF Industries Holdings Inc. and Potash Corp. of Saskatchewan Inc. ( POT - Analyst Report ) , maintains a Zacks #1 Rank, implying a short-term (1 to 3 months) Strong Buy rating
Read the full Analyst Report on POT
Read the full Analyst Report on CF
Read the full Analyst Report on AGU